Potential role of subcutaneous tocilizumab injections in patients with COVID-19 associated pneumonia.

Greco, Giuseppe; Ripamonti, Diego; Binda, Francesca; Fabretti, Fabrizio; Grazioli, Lorenzo; Rizzi, Marco

Greco, Giuseppe; Ripamonti, Diego; Binda, Francesca; Fabretti, Fabrizio; Grazioli, Lorenzo; Rizzi, Marco.

Greco G; Division of Infectious Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy.
Ripamonti D; Division of Infectious Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy.
Binda F; Division of Infectious Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy.
Fabretti F; Anesthesiology Department, ASST Papa Giovanni XXIII, Bergamo, Italy.
Grazioli L; Anesthesiology Department, ASST Papa Giovanni XXIII, Bergamo, Italy.
Rizzi M; Division of Infectious Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy.

J Med Virol ; 93(2): 686-688, 2021 02.

Article in English | MEDLINE | ID: covidwho-746413

Subject(s)

Antibodies, Monoclonal, Humanized/administration & dosage; Antibodies, Monoclonal, Humanized/therapeutic use; COVID-19/complications; COVID-19/therapy; Adult; Aged; Female; Humans; Injections, Subcutaneous; Male; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / COVID-19 Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.26494

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google